Elfabrio 2 mg/mL concentrate for solution for infusion
*Company:
Chiesi LimitedStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company
Educational materials 'FOR HEALTHCARE PROFESSIONALS' (HCPs) are additional risk minimisation measures that are intended to promote the safe and effective use of the medicinal product.
(Click to Download) ELFABRIO®▼ (PEGUNIGALSIDASE ALFA) IMPORTANT INFORMATION: on minimising the risk of hypersensitivity reactions and medication errors in home settings: Information for Patients, Caregivers and HCPs
Risk Minimisation Materials
(Click to Download) ELFABRIO®▼ (PEGUNIGALSIDASE ALFA) IMPORTANT INFORMATION on minimising the risk of hypersensitivity reactions and medication errors in home settings: Logbook
Risk Minimisation Materials
(Click to Download) ELFABRIO®▼ (PEGUNIGALSIDASE ALFA) IMPORTANT INFORMATION on minimising the risk of hypersensitivity reactions and medication errors in home settings: IHCPs
Risk Minimisation Materials
Chiesi Limited
Address:
Chiesi Limited, 333 Styal Road, Manchester, M22 5LGMedical Information E-mail:
Medinfo.uk@chiesi.comTelephone:
+44 (0) 161 488 5555 , 1800 817 459Website:
https://www.chiesi.uk.com https://www.chiesimedical.co.ukMedical Information Direct Line:
+44 (0)1748 827 271Stock Availability:
CustomerServices.UK@chiesi.com